NorthWest Biotherapeutics Inc (NWBO)

[Reefrad]

There will definitely be a rebuttal to this rebuttal as this “paper” basically calls into question the methodology of the Lia by calling them out for using the term “prospective”. This is an outrageous accusation, “the investigators had seen the data… and then decided to go ahead with the cross trial comparison”.

Clearly this cannot be true as this would be a major violation of academic integrity. Furthermore, there is zero chance a journal like Jama would allow the original paper to be published as is if this were the case.